The Rise In Long-Lasting And Communicable Diseases Fueling Market Growth Due To Increasing Transmission And Need For Advanced Immunotherapies Is Supporting Development Across The mRNA Therapeutics Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Value Trend Is Expected For The mRNA Therapeutics Market From 2026 To 2030?

The mRNA therapeutics market size has demonstrated steady growth in recent years. It is anticipated to expand from $35.9 billion in 2025 to $37.18 billion in 2026, registering a compound annual growth rate (CAGR) of 3.6%. The historical expansion of this market can be attributed to the remarkable achievements of mRNA vaccines in combating infectious diseases, advancements in nucleic acid delivery technologies, a deeper understanding of gene expression control, initial research validation of mRNA-based protein synthesis, and robust public funding for mRNA research platforms.

The mrna therapeutics market size is anticipated to experience consistent expansion in the coming years. It is projected to reach $42.32 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 3.3%. This growth during the forecast period can be attributed to factors such as increasing demand for targeted and personalized therapies, the broadening of mrna applications in oncology and rare diseases, escalating biopharmaceutical investment in mrna pipelines, a growing number of mrna drugs advancing into clinical trials, and strategic alliances between biotech firms and research organizations. Significant trends expected during this period include the diversification of mrna therapeutics beyond vaccines, a heightened focus on protein replacement therapies utilizing mrna, an expanding clinical pipeline for non-vaccine mrna drugs, greater investment in lipid nanoparticle delivery systems, and the accelerated development of end-to-end mrna manufacturing capabilities.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17205&type=smp

What Primary Factors Are Fueling The Expansion Of The mRNA Therapeutics Market?

The future expansion of the mRNA therapeutics market is expected to be propelled by the rising occurrence of chronic and transmissible illnesses. These conditions, which include tuberculosis, HIV/AIDS, and hepatitis, are defined as diseases that persist for extended periods and are capable of spreading between individuals. The surge in these diseases is attributed to factors such as increased global movement and gaps in healthcare infrastructure, which contribute to higher transmission rates and hinder effective disease management. mRNA therapeutics facilitate improved disease control by quickly enabling the body to produce proteins that enhance immune responses, thereby accelerating the development of targeted vaccines and treatments. For example, in March 2024, the Centers for Disease Control and Prevention, a US-based government agency, indicated an increase in tuberculosis cases from 8,320 in 2022 to 9,615 in 2023, representing a rise of 1,295 cases. Thus, the increasing prevalence of long-lasting and communicable diseases is driving the growth of the mRNA therapeutics market.

How Is Segment Classification Applied In The mRNA Therapeutics Market?

The mrna therapeutics market covered in this report is segmented –

1) By Product: Vaccines, Drugs

2) By Application: Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Other Applications

3) By End Use: Hospitals And Clinics, Research Organizations, Other End Uses

Subsegments:

1) By Vaccines: Infectious Disease Vaccines, Cancer Vaccines, Other Therapeutic Vaccines

2) By Drugs: Oncology Drugs, Cardiovascular Drugs, Autoimmune Disease Drugs, Other mRNA-Based Drugs

What Trends Are Influencing The Future Of The mRNA Therapeutics Market?

Major companies in the mRNA therapeutics market are concentrating on developing innovative solutions, such as personalized neoantigen vaccines, to enhance immune response and improve survival outcomes for cancer patients. These personalized neoantigen vaccines are specific cancer treatments designed for each patient, utilizing unique tumor-specific mutations to stimulate the immune system to target and destroy cancer cells. For instance, in July 2023, Merck & Co., Inc., a US-based research-intensive biopharmaceutical company, collaborated with Moderna Therapeutics, Inc., a US-based biotechnology company, to launch a Phase 3 randomized clinical trial (V940-001). This trial aims to evaluate mRNA-4157 (V940) in combination with KEYTRUDA® (pembrolizumab) as an adjuvant treatment for patients with resected high-risk (Stage IIB-IV) melanoma. This study follows positive results from the Phase 2b KEYNOTE-942/mRNA-4157-P201 trial, which showed a significant benefit of the combination over KEYTRUDA® alone in reducing recurrence and the risk of distant metastasis. The Phase 3 trial seeks to confirm these findings by assessing relapse-free survival and distant metastasis-free survival as primary and secondary endpoints, respectively.

Who Are The Leading Firms Participating In The mRNA Therapeutics Market?

Major companies operating in the mrna therapeutics market are Pfizer Inc., Novartis AG, Sanofi AG, AstraZeneca plc, GlaxoSmithKline plc, Hoffmann-La Roche AG, Moderna Therapeutics Inc, BioNTech SE, Vertex Pharmaceuticals Incorporated, Catalent Inc, Alnylam Pharmaceuticals Inc, Sarepta Therapeutics Inc, Arcturus Therapeutics Holdings Inc, CureVac N.V, Ethris GMBH, eTheRNA immunotherapies NV, In-Cell-Art S.A.S., Nutcracker Therapeutics Inc, SCM LifeScience Co Ltd, Suzhou Abogen Biosciences Co Ltd, Tiba Biotech LLC, CSPC Pharmaceutical Group, CRISPR Therapeutics AG

Access The Complete mRNA Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report

Which Region Holds The Largest Share In The mRNA Therapeutics Market?

North America was the largest region in the mRNA therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mrna therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access mRNA Therapeutics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=17205&type=smp

Browse Through More Reports Similar to the Global mRNA Therapeutics Market 2026, By The Business Research Company

Mrna Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report

Ribose Nucleic Acid Rna Based Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/ribose-nucleic-acid-rna-based-therapeutics-global-market-report

Rna Targeting Small Molecules Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/rna-targeting-small-molecules-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795